Table 1 Clinical and laboratorial characteristics
From: Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function
ACS | ACS-AKI | p | |
|---|---|---|---|
n (%) | 63 (80.7) | 15 (19.3) | |
Age | 58 (51–67) | 73 (63–78) | 0.001 |
Male (%) | 47 (74.6) | 11 (73.3) | 0.919 |
DM (%) | 27 (42.9) | 8 (53.3) | 0.463 |
HTN (%) | 35 (55.6) | 11 (73.3) | 0.136 |
SMK (%) | 41 (65.1) | 9 (60) | 0.712 |
NSTE-ACS(%) | 30 (47.6) | 10 (66.7) | 0.185 |
STEMI (%) | 33 (52.4) | 5 (33.3) | |
Death (%) | 2 (3.2) | 5 (33.3) | <0.001 |
BMI kg/m2 | 26.67 (24.22–29.4) | 26.56 (23.46–27.55) | 0.462 |
Heart rate | 75 (65–81) | 75 (64–86) | 0.849 |
SBP mmHg | 130.0 (116.0–150.0) | 120.0 (100.0–130.0) | 0.045 |
DBP mmHg | 80.0 (70.0–90.0) | 75.0 (70.0–80.0) | 0.206 |
Mean BP mmHg | 96.67 (85.67–110.0) | 90.67 (80.0–98.0) | 0.103 |
Hb g/L | 14.6 (13.7–15.3) | 14 (12.7–15.0) | 0.165 |
WBC ×109/L | 9.78 (7.88–12.2) | 12.8 (6.51–15.23) | 0.351 |
NT-ProBNP pg/mL | 1018.0 (217.7–2567.0) | 4746.0 (402.1–8519.0) | 0.034 |
TnI ng/mL | 9.92 (0.61–81.56) | 11.89 (0.19–37.06) | 0.596 |
hs-CRP mg/L | 9.75 (3.44–49.9) | 13.77 (5.67–169.79) | 0.29 |
Albumin mg/dL | 3.83 (3.6–4.02) | 3.82 (3.51–4.04) | 0.791 |
Na+ mmol/L | 140.0 (138.0–142.0) | 140.3 (136.7–144) | 0.817 |
K+ mmol/L | 4.07 (3.9–4.3) | 4.38 (3.93–4.94) | 0.101 |
BUN mg/dL | 16.36 (13.3–19.9) | 27.18 (21.18–38.0) | <0.001 |
HDL mg/dL | 35.8 (30.08–43.02) | 39.38 (30.58–49.7) | 0.303 |
LDL mg/dL | 96.63 (79.73–121.86) | 102.52 (67.36–111.55) | 0.368 |
T. Chol mg/dL | 160.36 (135.68–185.98) | 154.19 (122.75–171.27) | 0.274 |
TG mg/dL | 133.86 (102.72–197.1) | 105.7 (82.74–173.01) | 0.159 |
GRACE | 130 (96–152) | 156 (134–205) | 0.002 |
Admission Cr mg/dL | 0.958 (0.75–1.03) | 1.346 (1.02–1.8) | <0.001 |
Baseline Cr mg/dL | 0.803 (0.69–0.95) | 0.909 (0.682–1.084) | 0.482 |
ΔCr mg/dL | 0.057 (0.0–0.135) | 0.411 (0.331–0.8) | <0.001 |
Max Cr mg/dL | 0.97 (0.79–1.14) | 1.35 (1.03–1.9) | <0.001 |